(GRAY) – StreetInsider.com Reports
-
CalciMedica (CALC) Announces Private Placement of up to Approximately $55 Million
-
Graybug (GRAY) to Merge with CalciMedica in All-Stock Transaction
-
Graybug Vision (GRAY) Announces Review of Strategic Alternatives
-
Graybug Vision Inc. (GRAY) Halted, News Pending
-
Graybug Vision (GRAY) PT Lowered to $2 at Piper Sandler
-
Graybug Vision Inc. (GRAY) Appoints Dirk Sauer to its Board
-
Graybug Vision Inc. (GRAY) Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023
-
Cantor Fitzgerald Reiterates Overweight Rating on Graybug Vision (GRAY) with $4 PT, Believes Stock Deserves Greater Attention from Investors
-
Needham & Company Reiterates Hold Rating on Graybug Vision (GRAY)
-
Graybug Vision (GRAY) PT Lowered to $4 at Cantor Fitzgerald
-
Wedbush Assumes Graybug Vision (GRAY) at Neutral
-
Graybug Vision Inc. (GRAY) 30-day option implied volatility at 144
-
Pre-Open Stock Movers 06/11: (NOVN) (PGEN) (AMEH) Higher; (VRTX) (ELY) (SNOW) Lower (more...)
-
After-Hours Stock Movers 06/10: (PGEN) (AMEH) (ARWR) Higher; (VRTX) (ELY) (SNOW) Lower (more...)
-
Graybug Vision Inc. (GRAY) Climbs 38% Post-Market
-
Graybug Vision (GRAY) PT Lowered to $4 at Wedbush, Following Earnings
-
Needham & Company Downgrades Graybug Vision (GRAY) to Hold
-
SVB Leerink Downgrades Graybug Vision (GRAY) to Market Perform
-
Graybug Vision (GRAY) Reports Full-Data Analysis from 12-Month Treatment Phase of ALTISSIMO Phase 2b Trial in Wet AMD
-
Wedbush Downgrades Graybug Vision (GRAY) to Neutral
-
Graybug Vision (GRAY) PT Lowered to $23 at SVB Leerink, Following Clinical Update
-
Piper Sandler Downgrades Graybug Vision (GRAY) to Neutral
-
Graybug Vision Inc. (GRAY) Reports Preliminary Topline Results from Phase 2b ALTISSIMO Trial
-
Graybug Vision Inc. (GRAY) Reports Last Patient Visit in GB-102 Phase 2b ALTISSIMO Core Trial in Wet AMD
-
Cantor Fitzgerald Starts Graybug Vision (GRAY) at Overweight
-
UPDATE: Piper Sandler Starts Graybug Vision (GRAY) at Overweight; 'Meaningful AMD/DME Opportunity'
-
Oppenheimer Starts Graybug Vision (GRAY) at Outperform
-
Needham & Company Starts Graybug Vision (GRAY) at Buy
-
Graybug Vision Inc. (GRAY) IPO Opens 19% Higher
-
Graybug Vision Inc. (GRAY) Adds Christina Ackermann, Eric Bjerkholt and Julie Eastland to Board
-
UPDATE: Graybug Vision Inc. (GRAY) Prices 5.625M Share Upsized IPO at $16/Sh
Back to GRAY Stock Lookup